Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Shares Outstanding (Diluted Average) (2018 - 2024)

Skinvisible's Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $5.1 million for Q4 2024.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 11.49% to $5.1 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.1 million, a 11.49% increase, with the full-year FY2024 number at $5.1 million, up 11.49% from a year prior.
  • Shares Outstanding (Diluted Average) hit $5.1 million in Q4 2024 for Skinvisible, up from $4.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for SKVI hit a ceiling of $5.1 million in Q4 2024 and a floor of $4.5 million in Q1 2020.
  • Historically, Shares Outstanding (Diluted Average) has averaged $4.6 million across 5 years, with a median of $4.5 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 55.09% in 2020 and later changed 0.0% in 2021.
  • Tracing SKVI's Shares Outstanding (Diluted Average) over 5 years: stood at $4.5 million in 2020, then rose by 1.06% to $4.5 million in 2021, then changed by 0.0% to $4.5 million in 2022, then changed by 0.0% to $4.5 million in 2023, then increased by 11.49% to $5.1 million in 2024.
  • Business Quant data shows Shares Outstanding (Diluted Average) for SKVI at $5.1 million in Q4 2024, $4.5 million in Q3 2024, and $4.6 million in Q2 2024.